サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1269394

心房細動手術装置市場（術式：カテーテルアブレーション、外科的アブレーション）-世界の産業分析、規模、シェア、成長、動向、予測、2022-2031年

Atrial Fibrillation Surgery Devices Market (Procedure: Catheter Ablation and Surgical Ablation) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 170 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
心房細動手術装置市場（術式：カテーテルアブレーション、外科的アブレーション）-世界の産業分析、規模、シェア、成長、動向、予測、2022-2031年
出版日: 2023年03月08日
発行: Transparency Market Research
ページ情報: 英文 170 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

心房細動手術装置市場- 調査範囲：

本レポートでは、2022年を基準年、2031年を予測年として、2017年から2031年までの心房細動手術装置の世界市場の収益を提供します。また、2022年から2031年までの世界の心房細動手術装置市場のCAGRを掲載しています。

本レポートは、広範な調査を経て作成されました。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施し、調査作業の大部分を行っています。2次調査では、心房細動手術装置市場を理解するために、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照しました。

本レポートでは、世界の心房細動手術装置市場の競合情勢を掘り下げています。世界の心房細動手術装置市場で活動する主要企業が特定され、これらの各企業は様々な属性の観点からプロファイルされています。企業概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の心房細動手術装置市場におけるプレイヤーの属性です。

目次

第1章 序文

  • 市場の定義と範囲
  • 市場セグメンテーション
  • 主な調査目的
  • 調査ハイライト

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場の概要

  • イントロダクション
    • プロシージャの定義
  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 世界市場の分析と予測、2017-2031年
    • ポーターのファイブフォース分析

第5章 主要洞察

  • 世界各国の疾患有病率および発症率
  • 技術的進歩
  • 心房細動の概要
  • COVID-19パンデミックが業界に与える影響（バリューチェーン、短期・中期・長期的な影響）

第6章 世界市場分析・予測：手技別

  • イントロダクションと定義
  • 主な知見/発展
  • 市場価値予測：手技別、2017年～2031年
    • カテーテルアブレーション
      • ラジオ波焼灼療法
      • クライオアブレーション
    • 外科的アブレーション
      • コンバージェントアブレーション
      • メイズアブレーション
  • 市場魅力分析：施術別

第7章 世界市場分析・予測：エンドユーザー別

  • イントロダクション＆定義
  • 主な調査結果/発展状況
  • 市場規模予測：エンドユーザー別、2017年～2031年
    • 病院
    • 専門医院
    • 外来手術センター
    • その他
  • 市場魅力分析：エンドユーザー別

第8章 世界市場分析・予測：地域別

  • 主な調査結果
  • 市場価値予測：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ地域
  • 市場魅力分析：地域別

第9章 北米市場の分析・予測

  • イントロダクション
    • 主な調査結果
  • 市場価値予測：施術別、2017-2031年
    • カテーテルアブレーション
      • ラジオ波アブレーション
      • クライオアブレーション
    • 外科的アブレーション
      • コンバージェントアブレーション
      • メイズアブレーション
  • 市場価値予測：エンドユーザー別、2017-2031年
    • 病院
    • 専門医院
    • 外来手術センター
    • その他
  • 市場価値予測：国別、2017-2031年
    • 米国
    • カナダ
  • 市場魅力分析
    • 施術別
    • エンドユーザー別
    • 国別

第10章 欧州市場の分析と予測

  • イントロダクション
    • 主な調査結果
  • 市場価値予測：施術別、2017-2031年
    • カテーテルアブレーション
      • ラジオ波アブレーション
      • クライオアブレーション
    • 外科的アブレーション
      • コンバージェントアブレーション
      • メイズアブレーション
  • 市場価値予測：エンドユーザー別、2017-2031年
    • 病院
    • 専門医院
    • 外来手術センター
    • その他
  • 市場価値予測：国別／サブリージョン別、2017-2031年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 市場魅力分析
    • 手順別
    • エンドユーザー別
    • 国別／サブリージョン別

第11章 アジア太平洋地域の市場分析と予測

  • イントロダクション
    • 主な調査結果
  • 市場価値予測：施術別、2017-2031年
    • カテーテルアブレーション
      • ラジオ波アブレーション
      • クライオアブレーション
    • 外科的アブレーション
      • コンバージェントアブレーション
      • メイズアブレーション
  • 市場価値予測：エンドユーザー別、2017-2031年
    • 病院
    • 専門医院
    • 外来手術センター
    • その他
  • 市場価値予測：国別／サブリージョン別、2017-2031年
    • 中国
    • 日本
    • インド
    • オーストラリア・ニュージーランド
    • その他アジア太平洋地域
  • 市場の魅力分析
    • 手順別
    • エンドユーザー別
    • 国別／サブリージョン別

第12章 ラテンアメリカの市場分析・予測

  • イントロダクション
    • 主要な調査結果
  • 市場価値予測：施術別、2017-2031年
    • カテーテルアブレーション
      • ラジオ波アブレーション
      • クライオアブレーション
    • 外科的アブレーション
      • コンバージェントアブレーション
      • メイズアブレーション
  • 市場価値予測：エンドユーザー別、2017-2031年
    • 病院
    • 専門医院
    • 外来手術センター
    • その他
  • 市場価値予測：国別／サブリージョン別、2017-2031年
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 市場魅力分析
    • 施術別
    • エンドユーザー別
    • 国別／サブリージョン別

第13章 中東・アフリカ市場の分析・予測

  • イントロダクション
    • 主な調査結果
  • 市場価値予測：施術別、2017-2031年
    • カテーテルアブレーション
      • ラジオ波焼灼療法
      • クライオアブレーション
    • 外科的アブレーション
      • コンバージェントアブレーション
      • メイズアブレーション
  • 市場価値予測：エンドユーザー別、2017-2031年
    • 病院
    • 専門医院
    • 外来手術センター
    • その他
  • 市場価値予測：国別／サブリージョン別、2017-2031年
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ
  • 市場の魅力分析
    • 施術別
    • エンドユーザー別
    • 国別／サブリージョン別

第14章 競合情勢

  • 市場プレイヤー-競争マトリックス（階層別、企業規模別）
  • 市場シェア分析：企業別（2022年）
  • 企業プロファイル
    • AtriCure, Inc.
    • CardioFocus, Inc.
    • Abbott Laboratories
    • Biosense Webster, Inc.
    • Medtronic plc
    • Boston Scientific Corporation
    • Osypka AG
    • Kardium, Inc.
    • Acutus Medical, Inc.
    • Koninklijke Philips N.V.
図表

List of Tables

  • Table 01: Global Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 02: Global Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 03: Global Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 04: North America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 05: North America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: North America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: Europe Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 08: Europe Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Asia Pacific Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 11: Asia Pacific Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 12: Asia Pacific Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 13: Latin America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 14: Latin America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Latin America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 17: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 18: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

  • Figure 01: Global Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 03: Global Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 04: Global Atrial Fibrillation Surgery Devices Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 05: Global Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 06: Global Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 07: Global Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 08: North America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 09: North America Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 10: North America Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 11: North America Atrial Fibrillation Surgery Devices Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 12: North America Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 13: North America Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 14: North America Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 15: Europe Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 16: Europe Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 17: Europe Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 18: Europe Atrial Fibrillation Surgery Devices Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 19: Europe Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 20: Europe Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 21: Europe Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 22: Asia Pacific Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 23: Asia Pacific Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 24: Asia Pacific Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 25: Asia Pacific Atrial Fibrillation Surgery Devices Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 26: Asia Pacific Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 27: Asia Pacific Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 28: Asia Pacific Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 29: Latin America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 30: Latin America Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 31: Latin America Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 32: Latin America Atrial Fibrillation Surgery Devices Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 33: Latin America Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 34: Latin America Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 35: Latin America Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 36: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 37: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 38: Middle East & Africa Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 39: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 40: Middle East & Africa Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 41: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 42: Middle East & Africa Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 43: Global Atrial Fibrillation Surgery Devices Market Share Analysis, by Company, 2022
目次
Product Code: TMRGL85475

Atrial Fibrillation Surgery Devices Market - Scope of Report:

TMR's report on the global atrial fibrillation surgery devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global atrial fibrillation surgery devices market for the period 2017-2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global atrial fibrillation surgery devices market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the atrial fibrillation surgery devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global atrial fibrillation surgery devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global atrial fibrillation surgery devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global atrial fibrillation surgery devices market.

The report delves into the competitive landscape of the global atrial fibrillation surgery devices market. Key players operating in the global atrial fibrillation surgery devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global atrial fibrillation surgery devices market profiled in this report.

Key Questions Answered in Global Atrial Fibrillation Surgery Devices Market Report:

  • What is the sales/revenue generated by atrial fibrillation surgery devices across all regions during the forecast period?
  • What are the opportunities in the global atrial fibrillation surgery devices market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Atrial Fibrillation Surgery Devices Market - Research Objectives and Research Approach:

The comprehensive report on the global atrial fibrillation surgery devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global atrial fibrillation surgery devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global atrial fibrillation surgery devices market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Atrial Fibrillation Surgery Devices Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Procedure Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, 2017-2031
    • 4.4.1. Porter's Five Forces Analysis

5. Key Insights

  • 5.1. Disease Prevalence & Incidence Rate Globally With Key Countries
  • 5.2. Technological Advancements
  • 5.3. Overview of Atrial Fibrillation
  • 5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, by Procedure

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Procedure, 2017-2031
    • 6.3.1. Catheter Ablation
      • 6.3.1.1. Radiofrequency Ablation
      • 6.3.1.2. Cryoablation
    • 6.3.2. Surgical Ablation
      • 6.3.2.1. Convergent Ablation
      • 6.3.2.2. Maze Ablation
  • 6.4. Market Attractiveness Analysis, by Procedure

7. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Centers
    • 7.3.3. Ambulatory Surgical Centers
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Atrial Fibrillation Surgery Devices Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Procedure, 2017-2031
    • 9.2.1. Catheter Ablation
      • 9.2.1.1. Radiofrequency Ablation
      • 9.2.1.2. Cryoablation
    • 9.2.2. Surgical Ablation
      • 9.2.2.1. Convergent Ablation
      • 9.2.2.2. Maze Ablation
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Centers
    • 9.3.3. Ambulatory Surgical Centers
    • 9.3.4. Others
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Procedure
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Atrial Fibrillation Surgery Devices Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Procedure, 2017-2031
    • 10.2.1. Catheter Ablation
      • 10.2.1.1. Radiofrequency Ablation
      • 10.2.1.2. Cryoablation
    • 10.2.2. Surgical Ablation
      • 10.2.2.1. Convergent Ablation
      • 10.2.2.2. Maze Ablation
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Hospitals
    • 10.3.2. Specialty Centers
    • 10.3.3. Ambulatory Surgical Centers
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Procedure
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Atrial Fibrillation Surgery Devices Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Procedure, 2017-2031
    • 11.2.1. Catheter Ablation
      • 11.2.1.1. Radiofrequency Ablation
      • 11.2.1.2. Cryoablation
    • 11.2.2. Surgical Ablation
      • 11.2.2.1. Convergent Ablation
      • 11.2.2.2. Maze Ablation
  • 11.3. Market Value Forecast, by End-user, 2017-2031
    • 11.3.1. Hospitals
    • 11.3.2. Specialty Centers
    • 11.3.3. Ambulatory Surgical Centers
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Procedure
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Atrial Fibrillation Surgery Devices Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Procedure, 2017-2031
    • 12.2.1. Catheter Ablation
      • 12.2.1.1. Radiofrequency Ablation
      • 12.2.1.2. Cryoablation
    • 12.2.2. Surgical Ablation
      • 12.2.2.1. Convergent Ablation
      • 12.2.2.2. Maze Ablation
  • 12.3. Market Value Forecast, by End-user, 2017-2031
    • 12.3.1. Hospitals
    • 12.3.2. Specialty Centers
    • 12.3.3. Ambulatory Surgical Centers
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Procedure
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Atrial Fibrillation Surgery Devices Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Procedure, 2017-2031
    • 13.2.1. Catheter Ablation
      • 13.2.1.1. Radiofrequency Ablation
      • 13.2.1.2. Cryoablation
    • 13.2.2. Surgical Ablation
      • 13.2.2.1. Convergent Ablation
      • 13.2.2.2. Maze Ablation
  • 13.3. Market Value Forecast, by End-user, 2017-2031
    • 13.3.1. Hospitals
    • 13.3.2. Specialty Centers
    • 13.3.3. Ambulatory Surgical Centers
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Procedure
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company (2022)
  • 14.3. Company Profiles
    • 14.3.1. AtriCure, Inc.
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. CardioFocus, Inc.
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. Abbott Laboratories
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Biosense Webster, Inc.
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Medtronic plc
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. SWOT Analysis
    • 14.3.6. Boston Scientific Corporation
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. SWOT Analysis
    • 14.3.7. Osypka AG
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. SWOT Analysis
    • 14.3.8. Kardium, Inc.
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. Financial Overview
      • 14.3.8.4. SWOT Analysis
    • 14.3.9. Acutus Medical, Inc.
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. Financial Overview
      • 14.3.9.4. SWOT Analysis
    • 14.3.10. Koninklijke Philips N.V.
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Product Portfolio
      • 14.3.10.3. Financial Overview
      • 14.3.10.4. SWOT Analysis
      • 14.3.10.5. Strategic Overview